2017 Multidisciplinary Thoracic Cancers Symposium

March 16-18, 2017

San Francisco, CA

  • Support for the 2017 Multidisciplinary Thoracic Cancers Symposium Virtual Meeting is provided by:

About This Virtual Meeting

March 16-18, 2017

Marriott Marquis
San Francisco, CA

The 2017 Multidisciplinary Thoracic Cancer Symposium is a two-and-a-half day meeting featuring interactive case discussions; educational sessions on new multidisciplinary therapies, new targeted therapies, immunotherapy, treatment and screening guidelines, supportive care; and oral abstract sessions highlighting the most current, evidence-based practices. The goal of this meeting is to provide participants with updates on current early phase clinical and translational initiatives in thoracic malignancies, including targeted therapy, immunotherapy, advanced radiation and surgical methodologies, and pathological advancements in molecular categorization that are relevant to daily clinical practice. Additionally, there are updates on the appropriate integration of all the advancements in daily practice, including indication, patient selection, combinations of different therapeutic modalities, prevention and management of common toxicities.

Highlights include:

  • Meeting content focused on practical, relevant data.
  • Sessions on guidelines and case presentations that can be implemented in community practices.
  • Oral abstract sessions with the most current clinical and translational research.
  • Keynote speakers covering the hot topics in the field.
  • Interactive and discussion-based sessions.
  • Attendee networking opportunities.

Support for the 2017 Multidisciplinary Thoracic Cancers Symposium Virtual Meeting is provided by: Bristol Myers Squibb.

  • 2017 Multidisciplinary Thoracic Cancers Symposium Virtual Meeting
    Nonmember $150 Member $150

Enhanced Player Features

  • Variable Speed Playback
  • Peer-to-Peer questions
  • Add notes and bookmark sections to review later
  • Rate sessions
  • Share via social media